地莫西泮结构式
|
常用名 | 地莫西泮 | 英文名 | Demoxepam |
---|---|---|---|---|
CAS号 | 963-39-3 | 分子量 | 286.71300 | |
密度 | 1.37g/cm3 | 沸点 | 447.4ºC at 760mmHg | |
分子式 | C15H11ClN2O2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 224.4ºC | |
符号 |
GHS02, GHS07 |
信号词 | Danger |
地莫西泮用途Demoxepam 是 Chlordiazepoxide 的主要代谢产物。Demoxepam 对癌细胞系表现出细胞毒性活性。 Demoxepam 具有抗惊厥和抗焦虑作用。 |
中文名 | 地莫西泮 |
---|---|
英文名 | 7-chloro-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-one |
中文别名 | 7-氯-1,3-二氢-5-苯基-2H-1,4-苯并二氮杂-2-酮 4-氧化物 | 7-氯-5-苯基-1,3-二氢-2H-1,4-苯并二氮杂卓-2-酮-4-氧化物 |
英文别名 | 更多 |
描述 | Demoxepam 是 Chlordiazepoxide 的主要代谢产物。Demoxepam 对癌细胞系表现出细胞毒性活性。 Demoxepam 具有抗惊厥和抗焦虑作用。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.37g/cm3 |
---|---|
沸点 | 447.4ºC at 760mmHg |
分子式 | C15H11ClN2O2 |
分子量 | 286.71300 |
闪点 | 224.4ºC |
精确质量 | 286.05100 |
PSA | 57.85000 |
LogP | 2.73660 |
折射率 | 1.682 |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:1 3.氢键受体数量:3 4.可旋转化学键数量:1 5.互变异构体数量:2 6.拓扑分子极性表面积:52.9 7.重原子数量:20 8.表面电荷:0 9.复杂度:554 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS02, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H225-H302 + H312 + H332-H319 |
警示性声明 | P210-P261-P302 + P352 + P312-P304 + P340 + P312-P337 + P313-P403 + P235 |
危险品运输编码 | UN 1648 3 / PGII |
海关编码 | 2933990090 |
~0% 地莫西泮 963-39-3
详细
|
文献:US6815543 B1, ; Page column 8-10 ; |
~% 地莫西泮 963-39-3 |
文献:Psychopharmacology, , vol. 208, # 4 p. 555 - 562 |
海关编码 | 2933990090 |
---|---|
中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Liquid chromatography of demoxepam and phenothiazines using a post-column photochemical reactor and fluorescence detection.
J. Chromatogr. A. 217 , 463-71, (1981) Upon irradiation with short-wavelength UV light the tranquillizer demoxepam is converted into a highly fluorescent product. This reaction serves as a sensitive and selective means of detection of low ... |
|
The rapid hydrolysis of chlordiazepoxide to demoxepam may affect the outcome of chronic osmotic minipump studies.
Psychopharmacology 208(4) , 555-62, (2010) In chronic studies, the classical benzodiazepine chlordiazepoxide (CDP) is often the preferred drug because, unlike other benzodiazepines, it is soluble in water. However, rapid CDP hydrolysis in solu... |
|
Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the rat.
J. Chromatogr. A. 277 , 201-8, (1983) Rapid and sensitive methods are described for determining lorazepam and for determining chlordiazepoxide and its metabolites in brain tissue of the rat. Lorazepam was determined by means of solvent ex... |
7-chloro-5-phenyl-1, 3-dihydro-2H-1, 4-benzodiazpine-2-one-4-oxide |
Demoxepam |
CHLORDIAZEPOXIDE RELATED COMPOUND A |
7-Chloro-5-phenyl-1,5-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide |
7-CHLORO-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE-4-OXIDE |
Ro 5-2092 |
Ro 5-2092 lactam |
Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) |
7-CHLORO-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE 4-OXIDE |
7-CHLORO-1,3-DIHYDRO-5-PHENYL-1,4-BENZODIAZEPIN-2-ONE-4-OXID |
nordiazepam 4-oxide |
7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-one-4-oxide |
7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one-4-oxide |
Chlordiazepoxide lactam |
5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one 4-N-oxide |